Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men :
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men :
Non-steroidal anti-inflammatory drugs and cancer in Finnish men :
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
location:
Tampere
organizer:
Tampere University Press
publisher
Tampere University Press
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality
Non-steroidal anti-inflammatory drugs and cancer in Finnish men : an epidemiologic study on prostate cancer risk, survival and overall cancer mortality